نتائج البحث - "Ługowska, Iwona"

1

دورية أكاديمية

CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study

المساهمون: A.M. Frezza, S. Stacchiotti, F. Chibon, J. Coindre, A. Italiano, C. Romagnosa, S. Bagué, A.P. Dei To, L. Braglia, E. Palmerini, V. Quagliuolo, J.M. Broto, A. Lopez Pousa, G. Grignani, A. Brunello, J. Blay, R.D. Beveridge, I. Lugowska, T. Lesluye, R. Maestro, F.D. Merlo, P.G. Casali, A. Gronchi

مصطلحات موضوعية: CINSARC, chemotherapy, outcome, prognostication, sarcoma, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35848358; info:eu-repo/semantics/altIdentifier/wos/WOS:000826330900001; journal:CANCER MEDICINE; https://hdl.handle.net/2434/945833Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85134396277

الإتاحة: https://doi.org/10.1002/cam4.5015Test
https://hdl.handle.net/2434/945833Test

View record in BASE

2

دورية أكاديمية

Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial

المساهمون: PharmaMar, European Commission, Pasquali, Sandro, Palmerini, Emanuela, Grignani, Giovanni, Brunello, Antonella, Blay, Jean-Yves, Stacchiotti, Silvia

مصطلحات موضوعية: Chemotherapy, Clinical trial, Neoadjuvant, Nomogram, Sarcoma

العلاقة: #PLACEHOLDER_PARENT_METADATA_VALUE#; info:eu-repo/grantAgreement/EC/FP7/278472; https://doi.org/10.1002/cncr.33895Test; Sí; Cancer 128(1): 85-93 (2022); http://hdl.handle.net/10261/306933Test; 2-s2.0-85116932179; https://api.elsevier.com/content/abstract/scopus_id/85116932179Test

الإتاحة: https://doi.org/10.1002/cncr.33895Test
http://hdl.handle.net/10261/306933Test
https://api.elsevier.com/content/abstract/scopus_id/85116932179Test

View record in BASE

النص الكامل

3

دورية أكاديمية

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

المساهمون: Gronchi, Alessandro, Ferrari, Stefano, Quagliuolo, Vittorio, Broto, Javier Martin, Pousa, Antonio Lopez, Grignani, Giovanni, Basso, Umberto, Blay, Jean-Yve, Tendero, Oscar, Beveridge, Robert Diaz, Ferraresi, Virginia, Lugowska, Iwona, Merlo, Domenico Franco, Fontana, Valeria, Marchesi, Emanuela, Donati, Davide Maria, Palassini, Elena, Palmerini, Emanuela, De Sanctis, Rita, Morosi, Carlo, Stacchiotti, Silvia, Baguã©, Silvia, Coindre, Jean Michelle, Dei Tos, Angelo Paolo, Picci, Piero, Bruzzi, Paolo, Casali, Paolo Giovanni

مصطلحات موضوعية: Abdominal Wall, Adolescent, Adult, Aged, Anemia, Antineoplastic Combined Chemotherapy Protocol, Back, Chemotherapy, Adjuvant, Child, Dacarbazine, Deoxycytidine, Dioxole, Disease-Free Survival, Epirubicin, Etoposide, Extremitie, Human, Ifosfamide, Leiomyosarcoma, Liposarcoma, Myxoid, Middle Aged, Neoadjuvant Therapy, Neurilemmoma, Neutropenia, Risk Factor, Sarcoma, Synovial, Soft Tissue Neoplasm

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28499583; info:eu-repo/semantics/altIdentifier/wos/WOS:000402805700055; volume:18; issue:6; firstpage:812; lastpage:822; numberofpages:11; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/11573/1027799Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85019121722; http://www.journals.elsevier.com/the-lancet-oncologyTest/

الإتاحة: https://doi.org/10.1016/S1470-2045Test(17)30334-0
http://hdl.handle.net/11573/1027799Test
http://www.journals.elsevier.com/the-lancet-oncologyTest/

View record in BASE